$BCLI 4 SEC Filings

Filed On	Filing
28 Jul 2026	Form 4: Frenkel Jacob A, Director Received 100,000 shares as a grant or award
28 Jul 2026	Form 4: Pitts Peter Joe, Director Granted 900,000 Stock Option (Right to Buy)
29 May 2026	Form 4: Lebovits Chaim, President & CEO Received 1,800,000 shares as a grant or award
29 May 2026	Form 4: Yablonka Uri, Director Received 150,000 shares as a grant or award
29 May 2026	Form 4: Patlis Alla, See Remarks Received 100,000 shares as a grant or award
29 May 2026	Form 4: Frenkel Jacob A, Director Received 200,000 shares as a grant or award
29 May 2026	Form 4: Arbel Irit, Director Received 120,000 shares as a grant or award
20 May 2026	Form 4: Bairu Menghisteab, Director Granted 150,000 Stock Option (Right to Buy) ($105K)
20 May 2026	Form 4: Polverino Anthony J., Director Granted 150,000 Stock Option (Right to Buy) ($105K)
20 May 2026	Form 4: Hartounian Hartoun, Director Granted 225,000 Stock Option (Right to Buy) ($158K)
20 May 2026	Form 4: Lindborg Stacy, Director Granted 150,000 Stock Option (Right to Buy) ($105K)
20 May 2026	Form 4: Naor Nir, Director Granted 180,000 Stock Option (Right to Buy) ($126K)
20 May 2026	Form 4: Dagher Ibrahim B., Director Granted 225,000 Stock Option (Right to Buy) ($158K)
07 Jan 2025	Form 4: Dagher Ibrahim B., Chief Medical Officer Received 50,000 shares as a grant or award
03 Jan 2025	Form 4: Lebovits Chaim, President & CEO Received 120,000 shares as a grant or award
03 Jan 2025	Form 4: Frenkel Jacob A, Director Received 40,000 shares as a grant or award
03 Jan 2025	Form 4: Polverino Anthony J., Director Received 24,000 shares as a grant or award
03 Jan 2025	Form 4: Yablonka Uri, Director Received 60,000 shares as a grant or award
03 Jan 2025	Form 4: Patlis Alla, See Remarks Received 40,000 shares as a grant or award
03 Jan 2025	Form 4: Naor Nir, Director Received 30,666 shares as a grant or award

Comments